
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Treatment with the protease inhibitor Kaletra may cause opiate withdrawal symptoms in heroin addicts on methadone therapy, according to a study in the August 15 edition of Clinical Infectious Diseases. Kaletra can significantly lower the concentration of methadone in the blood, causing withdrawal symptoms, according to lead study author Elinore McCance-Katz of the Medical College of Virginia in Richmond. Methadone clearance from the body also was sped up when Kaletra was taken. 'I think the message for physicians treating [HIV-positive patients on methadone therapy] is that they need to be aware of all the patient's medications and any possible interactions,' McCance-Katz says. 'Informing the patient of possible interactions is particularly important because medication adherence is such a huge issue in this population.'
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video
Latest Stories
‘Kokomo City’ Gives a Searing Look Into Lives of Black Trans Sex Workers
August 18 2023 12:40 PM